Distribution and pharmacological characterization of primate NK-2 tachykinin receptor in the central nervous system of the rhesus monkey.
Masatoshi Nagano, Takao Oishi, Hidenori Suzuki
Index: Neurosci. Lett. 503(1) , 23-6, (2011)
Full Text: HTML
Abstract
Tachykinin NK-2 receptor, a cognate receptor for neurokinin A, expressed in the brain has been suggested as a new target for the treatment of psychiatric disorders. In rodents, treatment with NK-2 receptor agonists causes anxiogenic effects, while NK-2 receptor antagonists show anxiolytic and antidepressant-like effects. However, information about the distribution and functions of NK-2 receptors in the central nervous system (CNS) in primates is still lacking. Here, we examined the distribution and pharmacological profile of NK-2 receptors in the rhesus monkey (Macaca mulatta) to clarify the molecular basis of NK-2-mediated tachykininergic functions in the primate CNS. NK-2 receptors cloned from the rhesus monkey brain showed similar pharmacological properties to those of human NK-2 receptors. Substantial expression levels of NK-2 mRNA were observed in all the brain regions examined, including areas pertinent to the emotional networks such as the prefrontal cortex, cingulate cortex and amygdala. These findings suggest that NK-2 receptors may play important roles in the pathophysiology of psychiatric disorders.Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Related Compounds
Related Articles:
2013-04-01
[Inflammation 36(2) , 493-500, (2013)]
2013-02-01
[Neuropeptides 47(1) , 9-18, (2013)]
2012-06-01
[Exp. Lung Res. 38(5) , 233-49, (2012)]
2011-01-01
[J. Neuroinflammation 8 , 180, (2011)]
2013-04-01
[Pancreas 42(3) , 405-10, (2013)]